(-)-epigallocatechin 3-gallate increases expression ISO RGD:1348965 6480464 epigallocatechin gallate results in increased expression of HNRNPA1 protein CTD PMID:31195006 1,2-dimethylhydrazine increases expression ISO RGD:735271 6480464 1, 2-Dimethylhydrazine results in increased expression of HNRNPA1 mRNA CTD PMID:22206623 14-Deoxy-11,12-didehydroandrographolide increases expression ISO RGD:1348965 6480464 14-deoxy-11, 12-didehydroandrographolide results in increased expression of HNRNPA1 mRNA CTD PMID:22101062 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of HNRNPA1 mRNA CTD PMID:15576828 , PMID:17557909 17alpha-ethynylestradiol multiple interactions ISO RGD:735271 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HNRNPA1 mRNA CTD PMID:17942748 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of HNRNPA1 mRNA CTD PMID:20068009 1H-pyrazole increases expression ISO RGD:735271 6480464 pyrazole results in increased expression of HNRNPA1 protein CTD PMID:11901218 1H-pyrazole multiple interactions ISO RGD:735271 6480464 pyrazole promotes the reaction [HNRNPA1 protein binds to CYP2A5 mRNA] CTD PMID:11901218 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:735271 6480464 Tetrachlorodibenzodioxin results in increased expression of HNRNPA1 mRNA CTD PMID:17949056 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of HNRNPA1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:735271 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HNRNPA1 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:735271 6480464 Tetrachlorodibenzodioxin affects the expression of HNRNPA1 mRNA CTD PMID:21570461 2,4-dibromophenyl 2,4,5-tribromophenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:19954255 2,6-di-tert-butyl-4-methylphenol affects localization ISO RGD:735271 6480464 Butylated Hydroxytoluene affects the localization of HNRNPA1 protein CTD PMID:15390079 2,6-di-tert-butyl-4-methylphenol multiple interactions ISO RGD:735271 6480464 [Butylated Hydroxytoluene co-treated with Methylcholanthrene] affects the localization of HNRNPA1 protein, [Butylated Hydroxytoluene co-treated with Methylcholanthrene] results in increased expression of HNRNPA1 protein CTD PMID:15390079 2,6-di-tert-butyl-4-methylphenol increases expression ISO RGD:735271 6480464 Butylated Hydroxytoluene results in increased expression of HNRNPA1 protein CTD PMID:15390079 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of HNRNPA1 mRNA CTD PMID:21346803 2-hydroxypropanoic acid increases expression ISO RGD:1348965 6480464 Lactic Acid results in increased expression of HNRNPA1 mRNA CTD PMID:30851411 3',5'-cyclic UMP affects binding ISO RGD:1348965 6480464 HNRNPA1 protein binds to cyclic 3', 5'-uridine monophosphate CTD PMID:30528433 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:735271 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of HNRNPA1 mRNA CTD PMID:20188158 3-methylcholanthrene multiple interactions ISO RGD:735271 6480464 [Butylated Hydroxytoluene co-treated with Methylcholanthrene] affects the localization of HNRNPA1 protein, [Butylated Hydroxytoluene co-treated with Methylcholanthrene] results in increased expression of HNRNPA1 protein CTD PMID:15390079 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1, 2-dithiol-3-thione results in decreased expression of HNRNPA1 mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane increases expression ISO RGD:735271 6480464 4, 4'-diaminodiphenylmethane results in increased expression of HNRNPA1 mRNA CTD PMID:18648102 4-hydroxyphenyl retinamide increases expression ISO RGD:735271 6480464 Fenretinide results in increased expression of HNRNPA1 mRNA CTD PMID:28973697 5-fluorouracil decreases expression ISO RGD:1348965 6480464 Fluorouracil results in decreased expression of HNRNPA1 mRNA CTD PMID:16101138 5-fluorouracil multiple interactions ISO RGD:1348965 6480464 TP53 protein affects the reaction [Fluorouracil results in decreased expression of HNRNPA1 mRNA] CTD PMID:15016801 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of HNRNPA1 mRNA CTD PMID:24780913 acetamide increases expression EXP 6480464 acetamide results in increased expression of HNRNPA1 mRNA CTD PMID:31881176 acetylsalicylic acid decreases expression EXP 6480464 Aspirin results in decreased expression of HNRNPA1 mRNA CTD PMID:12800193 acrolein multiple interactions ISO RGD:1348965 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of HNRNPA1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of HNRNPA1 mRNA CTD PMID:32699268 actinomycin D multiple interactions ISO RGD:735271 6480464 Dactinomycin affects the reaction [HNRNPA1 protein binds to CYP2A5 mRNA] CTD PMID:12754101 actinomycin D affects localization ISO RGD:735271 6480464 Dactinomycin affects the localization of HNRNPA1 protein CTD PMID:12754101 aflatoxin B1 increases expression ISO RGD:735271 6480464 Aflatoxin B1 results in increased expression of HNRNPA1 mRNA CTD PMID:19770486 alachlor increases expression EXP 6480464 alachlor results in increased expression of HNRNPA1 mRNA CTD PMID:12419858 alpha-pinene multiple interactions ISO RGD:1348965 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of HNRNPA1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of HNRNPA1 mRNA CTD PMID:32699268 amiodarone increases expression ISO RGD:1348965 6480464 Amiodarone results in increased expression of HNRNPA1 mRNA CTD PMID:21163907 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of HNRNPA1 mRNA CTD PMID:16483693 aristolochic acid decreases expression ISO RGD:1348965 6480464 aristolochic acid I results in decreased expression of HNRNPA1 mRNA CTD PMID:33212167 Aroclor 1254 decreases expression ISO RGD:735271 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of HNRNPA1 mRNA CTD PMID:23650126 arsane affects methylation ISO RGD:1348965 6480464 Arsenic affects the methylation of HNRNPA1 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1348965 6480464 Arsenic affects the methylation of HNRNPA1 gene CTD PMID:25304211 arsenous acid increases expression ISO RGD:1348965 6480464 Arsenic Trioxide results in increased expression of HNRNPA1 mRNA CTD PMID:20458559 , PMID:25258189 benzo[a]pyrene decreases expression ISO RGD:1348965 6480464 Benzo(a)pyrene results in decreased expression of HNRNPA1 mRNA CTD PMID:20064835 benzo[a]pyrene increases expression ISO RGD:735271 6480464 Benzo(a)pyrene results in increased expression of HNRNPA1 mRNA CTD PMID:19770486 , PMID:22228805 benzo[a]pyrene increases expression ISO RGD:1348965 6480464 Benzo(a)pyrene results in increased expression of HNRNPA1 protein CTD PMID:25628927 benzo[a]pyrene multiple interactions ISO RGD:1348965 6480464 PARG affects the reaction [Benzo(a)pyrene results in increased expression of HNRNPA1 protein] CTD PMID:25628927 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1348965 6480464 7 more ... CTD PMID:26238291 beryllium sulfate increases expression ISO RGD:1348965 6480464 beryllium sulfate results in increased expression of HNRNPA1 mRNA CTD PMID:16314022 bisphenol A decreases expression ISO RGD:735271 6480464 bisphenol A results in decreased expression of HNRNPA1 mRNA CTD PMID:26063408 bisphenol A increases methylation ISO RGD:1348965 6480464 bisphenol A results in increased methylation of HNRNPA1 gene CTD PMID:31601247 bisphenol A decreases expression ISO RGD:1348965 6480464 bisphenol A results in decreased expression of HNRNPA1 mRNA CTD PMID:29275510 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of HNRNPA1 gene CTD PMID:28505145 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of HNRNPA1 mRNA CTD PMID:24136188 butanal increases expression ISO RGD:1348965 6480464 butyraldehyde results in increased expression of HNRNPA1 mRNA CTD PMID:26079696 butyric acid decreases expression EXP 6480464 Butyric Acid results in decreased expression of HNRNPA1 mRNA CTD PMID:12800193 cadmium atom increases oxidation ISO RGD:735271 6480464 Cadmium results in increased oxidation of HNRNPA1 protein CTD PMID:24077948 caffeine decreases expression ISO RGD:1348965 6480464 Caffeine results in decreased expression of HNRNPA1 protein CTD PMID:31195006 calcitriol decreases expression ISO RGD:1348965 6480464 Calcitriol results in decreased expression of HNRNPA1 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:1348965 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of HNRNPA1 mRNA CTD PMID:21592394 cannabidiol multiple interactions ISO RGD:1348965 6480464 [Cuprizone co-treated with Cannabidiol] results in decreased expression of HNRNPA1 protein CTD PMID:34122009 capsaicin increases expression EXP 6480464 Capsaicin results in increased expression of HNRNPA1 mRNA CTD PMID:20349343 carbon nanotube increases expression ISO RGD:735271 6480464 Nanotubes more ... CTD PMID:25620056 carvedilol multiple interactions ISO RGD:1348965 6480464 carvedilol promotes the reaction [ARRB1 protein binds to HNRNPA1 protein] CTD PMID:24334028 carvedilol multiple interactions ISO RGD:735271 6480464 carvedilol promotes the reaction [ARRB1 protein binds to HNRNPA1 protein] CTD PMID:24334028 cefaloridine increases expression EXP 6480464 Cephaloridine results in increased expression of HNRNPA1 mRNA CTD PMID:18500788 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of HNRNPA1 mRNA CTD PMID:23125180 choline multiple interactions ISO RGD:735271 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of HNRNPA1 mRNA CTD PMID:20938992 chromium(6+) affects expression ISO RGD:735271 6480464 chromium hexavalent ion affects the expression of HNRNPA1 mRNA CTD PMID:28472532 cisplatin increases expression ISO RGD:1348965 6480464 Cisplatin results in increased expression of HNRNPA1 protein CTD PMID:16803524 cisplatin decreases expression ISO RGD:735271 6480464 Cisplatin results in decreased expression of HNRNPA1 mRNA CTD PMID:21151649 colforsin daropate hydrochloride multiple interactions EXP 6480464 HNRNPA1 mutant form inhibits the reaction [Colforsin affects the splicing of RUNX1 exon], HNRNPA1 mutant form inhibits the reaction [Colforsin affects the splicing of SNAP25 exon] CTD PMID:22684629 copper atom increases expression ISO RGD:735271 6480464 Copper results in increased expression of HNRNPA1 protein CTD PMID:21146535 copper(0) increases expression ISO RGD:735271 6480464 Copper results in increased expression of HNRNPA1 protein CTD PMID:21146535 corticosterone decreases expression EXP 6480464 Corticosterone results in decreased expression of HNRNPA1 mRNA CTD PMID:15755911 crocidolite asbestos increases expression ISO RGD:735271 6480464 Asbestos, Crocidolite results in increased expression of HNRNPA1 mRNA CTD PMID:19446018 crocidolite asbestos decreases expression ISO RGD:735271 6480464 Asbestos, Crocidolite results in decreased expression of HNRNPA1 mRNA CTD PMID:29279043 Cuprizon multiple interactions ISO RGD:1348965 6480464 [Cuprizone co-treated with Cannabidiol] results in decreased expression of HNRNPA1 protein CTD PMID:34122009 curcumin decreases expression ISO RGD:1348965 6480464 Curcumin results in decreased expression of HNRNPA1 mRNA CTD PMID:17999991 diarsenic trioxide increases expression ISO RGD:1348965 6480464 Arsenic Trioxide results in increased expression of HNRNPA1 mRNA CTD PMID:20458559 , PMID:25258189 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of HNRNPA1 mRNA CTD PMID:17379624 dicrotophos decreases expression ISO RGD:1348965 6480464 dicrotophos results in decreased expression of HNRNPA1 mRNA CTD PMID:28302478 diuron decreases expression EXP 6480464 Diuron results in decreased expression of HNRNPA1 mRNA CTD PMID:21551480 doxorubicin affects expression ISO RGD:1348965 6480464 Doxorubicin affects the expression of HNRNPA1 protein CTD PMID:29385562 doxorubicin increases expression ISO RGD:1348965 6480464 Doxorubicin results in increased expression of HNRNPA1 mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of HNRNPA1 mRNA CTD PMID:29391264 enzyme inhibitor multiple interactions ISO RGD:1348965 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of HNRNPA1 protein CTD PMID:23301498 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of HNRNPA1 mRNA CTD PMID:17920746 flutamide increases expression EXP 6480464 Flutamide results in increased expression of HNRNPA1 mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:735271 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of HNRNPA1 mRNA CTD PMID:20938992 furan increases expression EXP 6480464 furan results in increased expression of HNRNPA1 mRNA CTD PMID:25539665 , PMID:26194646 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of HNRNPA1 mRNA CTD PMID:22061828 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of HNRNPA1 mRNA CTD PMID:33387578 glafenine increases expression EXP 6480464 Glafenine results in increased expression of HNRNPA1 mRNA CTD PMID:24136188 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of HNRNPA1 mRNA CTD PMID:24915197 hydrazine increases expression ISO RGD:735271 6480464 hydrazine results in increased expression of HNRNPA1 mRNA CTD PMID:15282401 irinotecan decreases expression ISO RGD:1348965 6480464 Irinotecan analog results in decreased expression of HNRNPA1 mRNA CTD PMID:18927307 ivermectin decreases expression ISO RGD:1348965 6480464 Ivermectin results in decreased expression of HNRNPA1 protein CTD PMID:32959892 josamycin affects response to substance ISO RGD:1348965 6480464 HNRNPA1 protein affects the susceptibility to Josamycin CTD PMID:31915244 L-methionine multiple interactions ISO RGD:735271 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of HNRNPA1 mRNA CTD PMID:20938992 lead(0) affects expression ISO RGD:1348965 6480464 Lead affects the expression of HNRNPA1 mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:1348965 6480464 Lead affects the expression of HNRNPA1 mRNA CTD PMID:28903495 methylmercury chloride decreases expression ISO RGD:1348965 6480464 methylmercuric chloride results in decreased expression of HNRNPA1 mRNA CTD PMID:28001369 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:1348965 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Thapsigargin affects the localization of HNRNPA1 protein], benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Tunicamycin affects the localization of HNRNPA1 protein] CTD PMID:23106379 N-methyl-4-phenylpyridinium increases expression ISO RGD:735271 6480464 1-Methyl-4-phenylpyridinium results in increased expression of HNRNPA1 protein CTD PMID:26558463 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of HNRNPA1 mRNA CTD PMID:19041683 nickel sulfate increases expression ISO RGD:1348965 6480464 nickel sulfate results in increased expression of HNRNPA1 mRNA CTD PMID:18651567 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of HNRNPA1 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1348965 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of HNRNPA1 mRNA more ... CTD PMID:32699268 paracetamol increases expression ISO RGD:1348965 6480464 Acetaminophen results in increased expression of HNRNPA1 mRNA CTD PMID:21420995 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of HNRNPA1 mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:1348965 6480464 Acetaminophen results in decreased expression of HNRNPA1 mRNA CTD PMID:29067470 paracetamol affects expression ISO RGD:735271 6480464 Acetaminophen affects the expression of HNRNPA1 mRNA CTD PMID:17562736 PCB138 increases expression EXP 6480464 2 more ... CTD PMID:23829299 pentachlorophenol increases expression ISO RGD:735271 6480464 Pentachlorophenol results in increased expression of HNRNPA1 mRNA CTD PMID:23892564 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of HNRNPA1 mRNA CTD PMID:19162173 phorone affects expression EXP 6480464 phorone affects the expression of HNRNPA1 mRNA CTD PMID:18198479 pirinixic acid affects expression EXP 6480464 pirinixic acid affects the expression of HNRNPA1 mRNA CTD PMID:19162173 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of HNRNPA1 mRNA CTD PMID:19162173 propiconazole decreases expression ISO RGD:735271 6480464 propiconazole results in decreased expression of HNRNPA1 mRNA CTD PMID:21278054 quercetin decreases expression ISO RGD:1348965 6480464 Quercetin results in decreased expression of HNRNPA1 protein CTD PMID:19207037 quercetin affects expression EXP 6480464 Quercetin affects the expression of HNRNPA1 mRNA CTD PMID:18178720 rac-lactic acid increases expression ISO RGD:1348965 6480464 Lactic Acid results in increased expression of HNRNPA1 mRNA CTD PMID:30851411 resveratrol decreases expression ISO RGD:735271 6480464 resveratrol results in decreased expression of HNRNPA1 protein CTD PMID:25505154 resveratrol multiple interactions ISO RGD:1348965 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of HNRNPA1 mRNA CTD PMID:23557933 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of HNRNPA1 protein CTD PMID:29459688 sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of HNRNPA1 mRNA CTD PMID:22110744 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of HNRNPA1 mRNA CTD PMID:25993096 sunitinib decreases expression ISO RGD:1348965 6480464 Sunitinib results in decreased expression of HNRNPA1 mRNA CTD PMID:31533062 testosterone multiple interactions ISO RGD:1348965 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of HNRNPA1 mRNA CTD PMID:21592394 testosterone decreases expression ISO RGD:1348965 6480464 Testosterone results in decreased expression of HNRNPA1 mRNA CTD PMID:21592394 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of HNRNPA1 mRNA CTD PMID:31150632 tetrachloromethane increases expression ISO RGD:735271 6480464 Carbon Tetrachloride results in increased expression of HNRNPA1 mRNA CTD PMID:31919559 thapsigargin affects localization ISO RGD:1348965 6480464 Thapsigargin affects the localization of HNRNPA1 protein CTD PMID:23106379 thapsigargin multiple interactions ISO RGD:1348965 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Thapsigargin affects the localization of HNRNPA1 protein], Thapsigargin promotes the reaction [HNRNPA1 protein binds to SREBF1 5' UTR] CTD PMID:23106379 thapsigargin affects localization EXP 6480464 Thapsigargin affects the localization of HNRNPA1 protein CTD PMID:23106379 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of HNRNPA1 mRNA CTD PMID:34492290 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of HNRNPA1 mRNA CTD PMID:25729387 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of HNRNPA1 mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:1348965 6480464 trichostatin A results in increased expression of HNRNPA1 mRNA CTD PMID:24935251 trimellitic anhydride increases expression ISO RGD:735271 6480464 trimellitic anhydride results in increased expression of HNRNPA1 mRNA CTD PMID:19042947 troglitazone decreases expression ISO RGD:735271 6480464 troglitazone results in decreased expression of HNRNPA1 mRNA CTD PMID:28973697 troglitazone decreases expression ISO RGD:1348965 6480464 troglitazone results in decreased expression of HNRNPA1 mRNA CTD PMID:19140230 tunicamycin increases activity ISO RGD:1348965 6480464 Tunicamycin results in increased activity of HNRNPA1 protein CTD PMID:23106379 tunicamycin multiple interactions ISO RGD:1348965 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Tunicamycin affects the localization of HNRNPA1 protein] more ... CTD PMID:23106379 tunicamycin multiple interactions EXP 6480464 HNRNPA1 mutant form inhibits the reaction [Tunicamycin results in increased expression of SREBF1 protein] CTD PMID:23106379 tunicamycin increases activity EXP 6480464 Tunicamycin results in increased activity of HNRNPA1 protein CTD PMID:23106379 tunicamycin affects localization ISO RGD:1348965 6480464 Tunicamycin affects the localization of HNRNPA1 protein CTD PMID:23106379 tunicamycin affects localization EXP 6480464 Tunicamycin affects the localization of HNRNPA1 protein CTD PMID:23106379 valproic acid decreases expression ISO RGD:735271 6480464 Valproic Acid results in decreased expression of HNRNPA1 mRNA CTD PMID:15799026 , PMID:21427059 valproic acid decreases expression ISO RGD:1348965 6480464 Valproic Acid results in decreased expression of HNRNPA1 mRNA CTD PMID:23179753 , PMID:27188386 valproic acid affects expression ISO RGD:735271 6480464 Valproic Acid affects the expression of HNRNPA1 mRNA CTD PMID:17292431 , PMID:17963808 vancomycin decreases expression ISO RGD:735271 6480464 Vancomycin results in decreased expression of HNRNPA1 mRNA CTD PMID:18930951 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of HNRNPA1 mRNA CTD PMID:22570695 Yessotoxin decreases expression ISO RGD:1348965 6480464 yessotoxin analog results in decreased expression of HNRNPA1 mRNA CTD PMID:30679557 zinc sulfate affects expression ISO RGD:1348965 6480464 Zinc Sulfate affects the expression of HNRNPA1 protein CTD PMID:25162517
